招股说明书
TriSalus Life(TLSI)05-01 05:05
$TriSalus Life(TLSI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-055016 Act: 33 Size: 61 KB 网页链接
简介:TriSalus Life Sciences, Inc.是一家特拉华州公司,于2009年成立。他们从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售,以改善难以治疗的肝癌和胰腺癌的治疗效果。他们的技术被用于提供治疗,并由介入放射科医生管理。他们正在开发和销售两个产品线——目前正在使用的压力药物输送系统(简称PEDD),以及一种研究药物SD-101,它显示出在治疗肝细胞癌、胰腺癌和其他肝脏实体瘤方面增强免疫系统反应的潜力。他们的PEDD with SmartValve 是唯一一种与心脏周期同步工作的技术,可以打开肿瘤内的塌陷血管,从而在肿瘤内高压的情况下实现更深的灌注并改善治疗药物的递送。PEDD与SmartValve已在前瞻性和回顾性临床研究和多个临床前模型中被证明可以改善治疗摄取和肿瘤反应。
今开:5.68 | 昨收:5.62 |
最高:5.79 | 最低:5.67 |
涨停价: | 跌停价: |
总市值:166837250 |
TriSalus Life(TLSI)05-01 05:05
$TriSalus Life(TLSI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-055016 Act: 33 Size: 61 KB 网页链接
TriSalus Life(TLSI)05-15 21:15
$TriSalus Life(TLSI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001826667-24-000017 Act: 34 Size: 7 MB 网页链接
TriSalus Life(TLSI)05-08 06:05
$TriSalus Life(TLSI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-24-012500 Size: 9 KB 网页链接
TriSalus Life(TLSI)06-26 18:05
$TriSalus Life(TLSI)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001946 Act: 33 Size: 1 KB 网页链接
TriSalus Life(TLSI)07-02 04:35
$TriSalus Life(TLSI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-076848 Act: 33 Size: 118 KB 网页链接
TriSalus Life(TLSI)05-24 18:55
$TriSalus Life(TLSI)$ SC TO-I Tender offer statement by Issuer Accession Number: 0001104659-24-064906 Act: 34 Size: 114 KB 网页链接
TriSalus Life(TLSI)07-20 04:55
$TriSalus Life(TLSI)$ ARS Annual Report to Security Holders Accession Number: 0001826667-24-000032 Act: 34 Size: 31 MB 网页链接
TriSalus Life(TLSI)05-24 19:15
$TriSalus Life(TLSI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-064921 Act: 33 Size: 74 KB 网页链接
TriSalus Life(TLSI)06-06 05:35
$TriSalus Life(TLSI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-015617 Size: 8 KB 网页链接
TriSalus Life(TLSI)05-15 20:35
$TriSalus Life(TLSI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-061631 Act: 34 Size: 316 KB 网页链接
$TriSalus Life(TLSI)$ DEF 14A Other definitive proxy statements Accession Number: 0001826667-24-000034 Act: 34 Size: 2 MB 网页链接
$TriSalus Life(TLSI)$ ARS Annual Report to Security Holders Accession Number: 0001826667-24-000032 Act: 34 Size: 31 MB 网页链接
$TriSalus Life(TLSI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019061 Size: 8 KB 网页链接
$TriSalus Life(TLSI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-076841 Act: 34 Size: 268 KB 网页链接
$TriSalus Life(TLSI)$ 425 Prospectuses and communications, business combinations Accession Number: 0001104659-24-076843 Act: 34 Size: 39 KB 网页链接
$TriSalus Life(TLSI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-076845 Act: 33 Size: 118 KB 网页链接
$TriSalus Life(TLSI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-076848 Act: 33 Size: 118 KB 网页链接
$TriSalus Life(TLSI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-076847 Act: 33 Size: 118 KB 网页链接
$TriSalus Life(TLSI)$ SC TO-I/A [Amend] Tender offer statement by Issuer Accession Number: 0001104659-24-075329 Act: 34 Size: 100 KB 网页链接
$TriSalus Life(TLSI)$ 425 Prospectuses and communications, business combinations Accession Number: 0001104659-24-075235 Act: 34 Size: 73 KB 网页链接